EDGAR Filing Documents for 0001193125-17-342673

Form 8-K - Current report:

SEC Accession No. 0001193125-17-342673

Filing Date

2017-11-14

Accepted

2017-11-14 16:55:01

Documents

Period of Report

2017-11-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d495806d8k.htm	8-K	17707
2	EX-1.1	d495806dex11.htm	EX-1.1	166539
3	EX-5.1	d495806dex51.htm	EX-5.1	5506
4	EX-99.1	d495806dex991.htm	EX-99.1	11864
5	GRAPHIC	g495806g1114091504182.jpg	GRAPHIC	3280
	Complete submission text file	0001193125-17-342673.txt		207491

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 171202512
SIC: 2834 Pharmaceutical Preparations